Acorda Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Acorda Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q2 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 1.24M shares, a 94.9% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.24M -23.1M -94.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.24M 0 0% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 1.24M -23.1M -94.9% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.24M -23M -94.9% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 24.3M +11.1M +83.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 1.24M 0 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 24.3M +13.1M +117% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 24.3M +13.2M +118% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 13.3M +3.81M +40.2% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 1.24M -8.23M -86.9% Dec 31, 2021 10-K 2024-04-01
Q3 2021 11.2M -36.5M -76.6% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 11.1M -36.6M -76.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 9.48M -38.3M -80.1% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 9.48M +1.51M +19% Dec 31, 2020 10-K 2022-03-18
Q3 2020 47.7M +194K +0.41% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 47.7M +199K +0.42% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 47.7M +171K +0.36% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 7.96M -39.5M -83.2% Dec 31, 2019 10-K 2021-03-16
Q3 2019 47.5M +230K +0.49% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 47.5M +312K +0.66% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 47.6M +839K +1.8% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 47.5M +1.07M +2.3% Dec 31, 2018 10-K 2020-02-28
Q3 2018 47.3M +590K +1.26% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 47.2M +566K +1.21% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 46.7M -46.1K -0.1% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 46.4M +761K +1.67% Dec 31, 2017 10-K 2019-02-27
Q3 2017 46.7M +576K +1.25% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 46.7M +554K +1.2% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 46.8M +796K +1.73% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 45.7M +2.68M +6.23% Dec 31, 2016 10-K/A 2018-03-09
Q3 2016 46.1M +3.26M +7.59% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 46.1M +3.27M +7.64% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 46M +3.18M +7.42% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 43M +1.12M +2.66% Dec 31, 2015 10-K 2017-02-27
Q3 2015 42.9M +1.65M +4.01% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 42.8M +1.76M +4.28% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 42.8M +1.76M +4.28% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 41.9M +987K +2.42% Dec 31, 2014 10-K 2016-02-29
Q3 2014 41.2M +613K +1.51% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 41.1M +1.03M +2.57% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 41M +1.15M +2.88% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 40.9M +1.09M +2.74% Dec 31, 2013 10-K 2015-02-27
Q3 2013 40.6M +1.13M +2.86% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 40M +575K +1.46% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 39.9M +471K +1.19% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 39.8M +476K +1.21% Dec 31, 2012 10-K 2014-03-03
Q3 2012 39.5M +373K +0.95% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 39.5M +360K +0.92% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 39.4M +615K +1.58% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 39.3M +549K +1.42% Dec 31, 2011 10-K 2013-02-28
Q3 2011 39.1M +553K +1.43% Sep 30, 2011 10-Q 2011-11-07
Q2 2011 39.1M +754K +1.97% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 38.8M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 38.8M Dec 31, 2010 10-K 2012-02-28
Q3 2010 38.6M Sep 30, 2010 10-Q 2010-11-09
Q2 2010 38.4M Jun 30, 2010 10-Q 2010-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.